PATENT CLAIM ANALYSIS

Application Number: 15771487
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "217060"]

Abstract:
To provide a compound having an inhibitory activity for an androgen receptor. A fused pyrimidine compound represented by the following formula (I) or a pharmaceutically acceptable thereof (in the formula, X, Y, Z, R 1 , and R 2  are as defined in the specification).

Claim (Index 4):
The compound or pharmaceutically acceptable salt thereof according to  claim 1 , wherein Y is a chlorine atom, a bromine atom, a trifluoromethyl group, a methoxy group, an isopropoxy group, or a methyl group.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 91.0
- Lexical Diversity: 1.375
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15203059', '15893804', '15023894', '13394525', '13796928']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8349625225075328
- 35 USC 102 Novelty (BERT): 0.5942572558934589
- Combined Prediction Score: 0.8108919958461254
- Mean Citation Score: 457.957174
- Max Citation Score: 524.8892
- Similarity Product: 453.97347422065735

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test